BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26493800)

  • 1. Risk stratification of normotensive pulmonary embolism: prognostic impact of copeptin.
    Hellenkamp K; Schwung J; Rossmann H; Kaeberich A; Wachter R; Hasenfuß G; Konstantinides S; Lankeit M
    Eur Respir J; 2015 Dec; 46(6):1701-10. PubMed ID: 26493800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism.
    Lankeit M; Jiménez D; Kostrubiec M; Dellas C; Kuhnert K; Hasenfuß G; Pruszczyk P; Konstantinides S
    Eur Respir J; 2014 Jun; 43(6):1669-77. PubMed ID: 24627529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study.
    Hellenkamp K; Pruszczyk P; Jiménez D; Wyzgał A; Barrios D; Ciurzyński M; Morillo R; Hobohm L; Keller K; Kurnicka K; Kostrubiec M; Wachter R; Hasenfuß G; Konstantinides S; Lankeit M
    Eur Respir J; 2018 Apr; 51(4):. PubMed ID: 29599188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac biomarkers and clinical scores for risk stratification in elderly patients with non-high-risk pulmonary embolism.
    Vuilleumier N; Limacher A; Méan M; Choffat J; Lescuyer P; Bounameaux H; Aujesky D; Righini M
    J Intern Med; 2015 Jun; 277(6):707-16. PubMed ID: 25285747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-adjusted high-sensitivity troponin T cut-off value for risk stratification of pulmonary embolism.
    Kaeberich A; Seeber V; Jiménez D; Kostrubiec M; Dellas C; Hasenfuß G; Giannitsis E; Pruszczyk P; Konstantinides S; Lankeit M
    Eur Respir J; 2015 May; 45(5):1323-31. PubMed ID: 25614162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
    Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
    Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker-based risk assessment model in acute pulmonary embolism.
    Kostrubiec M; Pruszczyk P; Bochowicz A; Pacho R; Szulc M; Kaczynska A; Styczynski G; Kuch-Wocial A; Abramczyk P; Bartoszewicz Z; Berent H; Kuczynska K
    Eur Heart J; 2005 Oct; 26(20):2166-72. PubMed ID: 15911566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism.
    Binder L; Pieske B; Olschewski M; Geibel A; Klostermann B; Reiner C; Konstantinides S
    Circulation; 2005 Sep; 112(11):1573-9. PubMed ID: 16144990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of cardiac biomarkers in the prediction of right ventricular dysfunction before echocardiography in acute pulmonary embolism.
    Choi HS; Kim KH; Yoon HJ; Hong YJ; Kim JH; Ahn Y; Jeong MH; Cho JG; Park JC; Kang JC
    J Cardiol; 2012 Dec; 60(6):508-13. PubMed ID: 22902901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NT-proBNP for risk stratification of pulmonary embolism].
    Dores H; Fonseca C; Leal S; Rosário I; Abecasis J; Monge J; Correia MJ; Bronze L; Leitão A; Arroja I; Aleixo A; Silva A
    Rev Port Cardiol; 2011 Dec; 30(12):881-6. PubMed ID: 22100750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No firm association between N-terminal pro-brain natriuretic peptide and percentage of pulmonary vascular obstruction in patients with acute pulmonary embolism.
    Agterof MJ; Schutgens RE; Verzijlbergen JF; van Buul MM; Tromp EA; Eijkemans MJ; van der Griend R; Biesma DH
    Thromb Res; 2011 Jun; 127(6):547-50. PubMed ID: 21421260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure.
    Pascual-Figal DA; Manzano-Fernández S; Boronat M; Casas T; Garrido IP; Bonaque JC; Pastor-Perez F; Valdés M; Januzzi JL
    Eur J Heart Fail; 2011 Jul; 13(7):718-25. PubMed ID: 21551163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein in acute pulmonary embolism.
    Abul Y; Karakurt S; Ozben B; Toprak A; Celikel T
    J Investig Med; 2011 Jan; 59(1):8-14. PubMed ID: 21218608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined risk stratification with computerized tomography /echocardiography and biomarkers in patients with normotensive pulmonary embolism.
    Ozsu S; Karaman K; Mentese A; Ozsu A; Karahan SC; Durmus I; Oztuna F; Kosucu P; Bulbul Y; Ozlu T
    Thromb Res; 2010 Dec; 126(6):486-92. PubMed ID: 20920821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study.
    Lankeit M; Jiménez D; Kostrubiec M; Dellas C; Hasenfuss G; Pruszczyk P; Konstantinides S
    Circulation; 2011 Dec; 124(24):2716-24. PubMed ID: 22082681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent NT-proBNP elevation in acute pulmonary embolism predicts early death.
    Kostrubiec M; Pruszczyk P; Kaczynska A; Kucher N
    Clin Chim Acta; 2007 Jul; 382(1-2):124-8. PubMed ID: 17507005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Cardiac and Non-Cardiac Biomarkers for Risk Stratification in Elderly Patients with Non-Massive Pulmonary Embolism.
    Vuilleumier N; Simona A; Méan M; Limacher A; Lescuyer P; Gerstel E; Bounameaux H; Aujesky D; Righini M
    PLoS One; 2016; 11(5):e0155973. PubMed ID: 27219621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal Pro-B type natriuretic peptide as long-term predictor of death after an acute pulmonary embolism.
    Alonso-Martínez JL; Annicchérico-Sánchez FJ; Urbieta-Echezarreta MA; Pérez-Ricarte S
    Med Clin (Barc); 2015 Mar; 144(6):241-6. PubMed ID: 24947203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.